Back to Search
Start Over
Alitretinoin for the treatment of severe chronic eczema of the hands
- Source :
- Expert Opinion on Pharmacotherapy. 23:159-167
- Publication Year :
- 2021
- Publisher :
- Informa UK Limited, 2021.
-
Abstract
- Introduction Chronic hand eczema (CHE) is a frequent skin disorder affecting up to 10% of the population and strongly reduces Quality of Life (QoL). The first-line therapeutic strategies for the management of CHE include a change of lifestyle, an education program for the skin and the application of specific emollients. Topical corticosteroids or calcineurin inhibitors are the most used anti-inflammatory drugs. However, up to 65% of patients require systemic options. Alitretinoin, a retinoid structurally related to vitamin A, is the first systemic treatment approved in the European Union (EU) for severe CHE refractory to potent topical corticosteroids. Areas covered This review summarizes the available data on the pharmacokinetics, pharmacodynamics, efficacy, and safety profile of oral alitretinoin for the treatment of CHE. Expert opinion Alitretinoin can be considered as a valid therapeutic option for the treatment of CHE in patients not responding to ordinary treatments. Clinical trials and real-life experiences showed that it acts effectively on both objective and subjective clinical signs, resulting in a significant improvement in QoL of patients. As for other retinoids, caution should be taken in patients with certain chronic diseases (hepatopathies, kidney failure, hyperlipidemia, thyroid dysfunction) or childbearing potential women.
- Subjects :
- medicine.medical_specialty
Population
Eczema
Tretinoin
Hand Dermatoses
Alitretinoin
Quality of life
medicine
Humans
media_common.cataloged_instance
Pharmacology (medical)
European union
education
media_common
Pharmacology
drug interaction
education.field_of_study
integumentary system
business.industry
General Medicine
Drug interaction
Dermatology
Calcineurin
Clinical trial
pharmacodynamic
Pharmacodynamics
Quality of Life
Female
chronic hand eczema
business
pharmacokinetics
medicine.drug
Subjects
Details
- ISSN :
- 17447666 and 14656566
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- Expert Opinion on Pharmacotherapy
- Accession number :
- edsair.doi.dedup.....3ac6921074623e20d2681258bf5cf35b